Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enterotoxigenic Escherichia coli surface antigens denote a highly diverse group of surface-exposed proteins critical for the initial binding and colonization of the human small intestine by ETEC. The best-characterized among these are the colonization factors (CFs) or coli surface antigens (CSs), which include several families of pili/fimbriae (such as CFA/I, CS3, CS23, CS26), assembled via the chaperone-usher pathway, as well as afimbrial adhesins. These antigens function primarily as adhesins, facilitating ETEC attachment to intestinal epithelial cells—an essential prerequisite for the subsequent delivery of enterotoxins (heat-labile and heat-stable toxins) that cause secretory diarrhea. Targeting these surface molecules has driven modern ETEC vaccine development, with antigens like CFA/I tip adhesin (CfaE) and YghJ being explored for recombinant subunit vaccines. Due to their central role in pathogenesis and immunogenicity, ETEC surface antigens are considered premier targets for both prophylactic and therapeutic interventions, although high antigenic variability and presence in nonpathogenic strains complicate universal targeting
Vaccines/antibodies: Block bacterial adhesion to host epithelial cells and prevent colonization and subsequent toxin delivery Transcriptional inhibitors (experimental): Block expression of CF antigens by targeting regulatory proteins (e.g., Rns via decanoic acid)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enterotoxigenic Escherichia coli colonization factor antigen (CFA, or CS).